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Library preparation protocols for high-throughput DNA sequencing (HTS) include amplification steps in
which errors can build up. In order to have confidence in the sequencing data, it is important to understand
the effects of different Taq polymerases and PCR amplification protocols on the DNAmolecules sequenced.
We compared thirteen enzymes in three different marker systems: simple, single copy nuclear gene and
complex multi-gene family. We also tested a modified PCR protocol, which has been suggested to reduce
errors associated with amplification steps. We find that enzyme choice has a large impact on the proportion
of correct sequences recovered. The most complex marker systems yielded fewer correct reads, and the
proportion of correct reads was greatly affected by the enzyme used. Modified cycling conditions did reduce
the number of incorrect sequences obtained in some cases, but enzyme had a much greater impact on the
number of correct reads. Thus, the coverage required for the safe identification of genotypes using one of the
low quality enzymes could be seven times larger than with more efficient enzymes in a biallelic system with
equal amplification of the two alleles. Consequently, enzyme selection for downstream HTS has important
consequences, especially in complex genetic systems.
H
igh throughput DNA sequencing (HTS) has dramatically reduced the cost per base sequenced1. HTS
technologies, however, are fundamentally different from Sanger sequencing and face different problems.
In HTS single molecules of DNA yield sequences, as opposed to a large pool of molecules in Sanger
sequencing. This exposes errors that can occur during library preparation. For example, errors could result from
the misincorporation of nucleotides during the amplification steps of library preparation. During amplification
there can be partial synthesis of a DNA strand that can act as a primer in a downstream polymerase chain reaction
(PCR) cycle and form a chimeric sequence if it amplifies a related allele. These sources of errors originating in PCR
amplification are poorly characterized, but increasingly recognized as a problem2,3.
Recent technical advances in HTS yielding longer reads of 350 to 1000 base pairs (bp) and methodological
advances such as the incorporation of index sequences allow multiple targeted loci from many individuals to be
sequenced simultaneously4–6. Targeted loci could have different characteristics. The simplest systems, such as loci
in themitochondrial DNA, Y chromosome (inmammals) orW chromosome (in birds) loci, are expected to yield
a single haplotype and are thus the easiest to determine the sequence of. Most single copy nuclear markers, which
are potentially biallelic in diploid organisms, are more challenging to accurately genotype. Very complex systems,
such as gene families in whichmany different alleles could be present in a single individual, can be very difficult to
accurately characterize. PCR based errors have been shown to be a problem in the characterization of polygenic
immune system loci in model organisms2,3. Accurately genotyping complex loci in non-model systems for which
there is not a lot of comparative data to verify results can be even more challenging7–10.
One factor that could play an important role in identifying correct alleles and genotypes using HTS approaches
is the enzyme used in the DNA amplification. In this study we tested the ability of thirteen different enzymes to
yield the true sequence(s) via HTS in three genetic marker systems of different complexity. We also tested if
modified PCR conditions could increase the yield of correct templates, as suggested in previous studies11–15.
Understanding the frequency and potential sources of erroneous sequences is of prime importance for the design
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of optimal protocols in HTS approaches to characterize genetic
diversity in individuals and populations, and is even more critical
in non-model systems.
Results
We tested the ability of 13 different enzymes to yield the true
sequence(s) in three different marker sets of varying complexity
(seeMethods, Table 1 for abbreviations). The three sets we usedwere:
Test 1, mitochondrial DNA from wolves, expected to yield a single
sequence per individual; Test 2, MHC class II exon 2 (MHC II) in
horses, a single copy nuclear gene with one or two alleles per indi-
vidual; and Test 3, MHC class I exon 3 (MHC I) in horses, a multi-
gene family which could yield several alleles per individual. Three
different individuals were included in each test. A further two tests
(Tests 2b and 3b) were designed to evaluate the ability of modified
PCR cycling conditions to reduce amplification-associated errors.
These tests were done only with the two more complex systems:
MHC II for Test 2b and MHC I for Test 3b.
Error patterns and rates can vary between sequencing plat-
forms1,16, and even independent runs in the same platform can have
an effect on the genotypes17. Here we focus on the performance of
different polymerase on a single platform in order to more reliably
assess to what degree this is an important factor to take into account
when designing experiments. We chose the Roche 454 Junior
sequencing platform. This platform is appropriate for this experi-
ment because it allows relatively long and variable read lengths, so the
entire length of the three different PCR products could be sequenced
simultaneously in single reads.
Six enzymes (Phusion, Gold, FastStart, Roche Taq, HotStar and
Biotaq) worked across all tests, five of them (Velocity, OneTaq, Imax,
KapHF and Pwo) worked inconsistently in different tests. We were
not able to get Vent or DeepVent to amplify in any of the systems
after 12–29 tries each for Tests 1–3. The sequencing run produced
102,484 reads, fromwhich 63,942 passed size (full length) and quality
filters (complete MID and primer sequences) and could be success-
fully assigned to the experimental units (Genetic system/Enzyme/
PCR condition/Biological replica) yielding an average coverage of
566, although with a large variation (standard deviation, s. d. 5
1900). The average coverage for the sequences used in Test 1 was
1004 (s. d.5 3225), 203 in Test 2 (s. d.5 194), 370 in Test 3 (s. d.5
484), 834 in Test 2b (s. d. 5 2300) and 337 in Test 3b (s. d. 5 546).
Eleven of the 13 enzymes tested yielded a band of the expected size in
Test 1, eight in Test 2, eight in Test 3, six in Test 2b and six in Test 3b.
There was a significant effect of the enzyme on the quality of the
sequences obtained (proportion of reads with a correct sequence) for
all tests (p , 0.001 in all cases). In general, Biotaq produced the
lowest portion of correct reads across all tests whereas Phusion,
Pwo and KapHF worked best (Supplementary File 1). For Test 1
(with only one allele expected per individual), all the enzymes that
successfully amplified DNA (11 out of 13) yielded from 50–53%
(OneTaq and Biotaq) to 88–92% (Phusion, Pwo and KapHF) correct
reads (Figure 1). For Test 2, the proportion of correct reads was on
average 23% lower than for Test 1. There was also more variation
between the enzymes, with correct reads ranging from 2% (Biotaq) to
84% (Phusion) (Figure 1). For Test 3, the multigene family marker
system, the recovery of correct sequences ranged from 17–20%
(Biotaq, HotStar and Roche Taq) to 65–71% (Phusion and
FastStart) (Figure 1).
For the systemwith up to 2 alleles, the modified PCR had no effect
on the proportion of correct reads (p5 0.31, Test 2 vs Test 2b). For
the complex system, the multigene family, the proportion of correct
readswas significantly higher under themodified PCR conditions, by
an average of 7.5% (p , 0.001, Test 3 vs Test 3b).
We used the proportion of correct sequences obtained with each
enzyme from Tests 1, 2 and 2b to calculate the probability of obtain-
ing three ormore copies of the correct allele(s).We simulated this for
a simple system, a haplotype (data from Test 1), and for a more
complex system, a single locus with two alleles (combined data from
Tests 2 & 2b). Unequal amplification of alleles in PCR reactions
where more than one allele are amplified has been observed
widely18,19. For this reason we also simulated the number of reads
needed to reach the same level of confidence when one allele in the
two allele system amplified twice as well as the other. For the haplo-
type, between 7 (for Phusion, Pwo andKapHF) and 16 (Biotaq) reads
were enough to have a 99.9% probability of obtaining 3 or more
correct sequences (Table 1, Figure 2A). However, the number of
reads required increased sharply as the gene system got more com-
plex. For two alleles that amplify equally, between 42 (for Phusion)
and 271 (Biotaq) reads were needed to have 99.9% confidence of
getting three correct copies for each of the two alleles (Table 1,
Figure 2B). In the case of unequal amplification, the coverage neces-
sary increased to 87 for Phusion, and to 395 for Biotaq (Table 1,
Figure 2C).
Discussion
The Taq polymerase enzyme used in the PCR steps of library pre-
paration for HTS had a very important impact on the proportion of
correct reads after sequencing. In the simplest case of a single allele
being present, as in mitochondrial DNA or sex specific chromosome
markers (Test 1), the majority of the reads (50–92%, depending on
Table 1 | Coverage necessary to reach a 99.9% probability of recovering three copies of the correct sequence for all alleles (based on the
proportion of correct reads). Since not all alleles in a PCR amplify equally well, we calculated the coverage needed when two alleles amplify
at the same rate (equal amplification), and when one allele yields twice as many products as the other (unequal amplification). Enzymes that
did not amplify are marked n.a. and those which amplified but for which there was insufficient data to calculate coverage are labeled i.d.
Abbreviations are those used in Figures 1 and 2 and the text
Enzyme Abbreviation Test 1 Test 2 equal amplification Test 2 unequal amplification
PhusionH High Fidelity DNA Polymerase (Finnzymes) Phusion 7 42 87
KAPA HiFiTM (Kapa Biosystems) KapHF 7 i.d. i.d.
PwoH DNA Polymerase (Roche) Pwo 7 n.a. n.a.
AmpliTaq GoldH (Applied Biosystems) Gold 9 48 88
i-MaxTM II DNA Polymerase (iNtRON Biotechnology) iMax 11 57 99
Taq DNA Polymerase (Roche) Roche Taq 11 120 185
Velocity DNA Polymerase (Bioline) Velocity 12 n.a. n.a.
HotStarTaqH DNA Polymerase (Qiagen) HotStar 14 97 152
FastStartH High Fidelity PCR System (Roche) FastStart 14 45 86
BiotaqH (Bioline) Biotaq 16 271 395
OneTaqTM DNA Polymerase (New England Biolabs) OneTaq i.d. n.a. n.a.
VentH DNA Polymerase (New England Biolabs) Vent n.a. n.a. n.a.
Deep VentH DNA Polymerase (New England Biolabs) DeepVent n.a. n.a. n.a.
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the enzyme) for all enzymes that worked (11 out of 13) had the
correct sequence. In this marker system, high confidence that the
haplotype identified is accurate was achieved with a low coverage of
73 for the best enzymes and 163 for the worst.
However, the proportion of correct reads went down in multi-
allelic systems. In the just slightly more complex system of a single
copy nuclear gene with two alleles (Test 2), the proportion of correct
reads went down by an average of 23% (Figure 1). Calculations based
on the proportion of sequences with the correct sequence revealed
that for the best enzymes, and assuming equal amplification of the
two alleles, 42 to 48 reads are necessary to have a high confidence in
the identification of genotypes (probabilities of 99.9% or higher for
the identification of each allele). The coverage required for the worse
enzymes was much larger (above 2703).
This difference became even more pronounced when the model
was more realistic and one allele amplified twice as well as the other.
In this case, the coverage necessary to reach a similar degree of
confidence in the results as for equal amplification of the alleles
almost doubled. Differences in the amplification success of the two
alleles in a biallelic system can realistically bemuch larger than a ratio
of 152. Thus, the coverage necessary to have high confidence in a
genotype would also be much higher. Cycling conditions also had a
significant effect on the proportion of correct reads in some cases, but
the effect was of a much smaller magnitude than the effect of the
enzymes.
The results presented here suggest that for the best enzymes, under
themost favorable PCR amplification conditions, and perfectly equal
amplification of the two alleles of a single copy nuclear gene in a
diploid organism, 42 to 48 reads are necessary to have a high con-
fidence in the identification of genotypes. For other enzymes and in
the more realistic case of unequal amplification of the alleles, nearly
400 reads are necessary to reach a similar degree of confidence in the
results. This greatly complicates the analysis of data because as the
number of incorrect reads goes up, the probability of these incorrect
reads also being present inmultiple copies also goes up. In the case of
a single copy nuclear gene in a diploid organism, the maximum
number of alleles that could be present is two, which reduces the
bioinformatic problem. In the case where there are an unknown
number of alleles, such as for MHC I, it may not be possible to
determine the real alleles even with very high coverage because the
frequency of reads that represent errorsmay grade into the frequency
of reads reflecting real alleles with poor relative amplification success.
Illumina and Ion Torrent platforms are increasing their read
lengths, and are now or soon will be useful for sequencing through
entire PCR products. Each platform has a different rate and pattern
of errors1,20,21. The sequences analyzed here were generated on the
Roche 454 platform. However, we expect the observed large differ-
ences in enzyme performance to be evident on the other HTS plat-
forms as well, although the exact coverage required for high
confidence in the results will likely be different. New library prepara-
tion protocols that target loci without being based on PCR, such as
hybridization-based enrichment, are being developed. However,
they still require PCR enrichment steps, so even with these protocols,
enzyme choice is important and can affect sequencing results.
Ideally, the necessary coverage for a particular system should be
calculated based on the observed bias in allele amplification and
errors in the enzyme and platform combination used in a particular
experiment. In planning a HTS project it is also important to keep in
mind that the numbers for coverage presented here to have confid-
ence in a particular haplotype or genotype are not average numbers
for a project, but minimum coverage numbers for each sample in a
study. Since the coverage of all individuals analyzed simultaneously
in a run is never exactly equal, the average coverage that should be
planned for in a study would thus be higher.
Methods
Samples. We used DNA samples from three gray wolves (Canis lupus) from which
the 59 end of themitochondrial control region had been Sanger sequenced in previous
studies, and thus was known22,23. The loci had different GC content, from 44% to 66%,
and the longest homopolymer was 5 bp (present in at least one allele of each locus).
Three Retuertas breed domestic horses (Equus caballus) with knownMHC genotypes
(Brandariz-Fontes et al. in preparation) were selected for the nuclear loci tests. Each
DNA sample was quantified using a NanoDrop ND-1000 Spectrophotometer
(NanoDrop Technologies, Inc., Wilmington, DE, USA), and the concentration was
adjusted to 10 or 30 ng/ml for subsequent PCR amplifications.
Taq polymerase. A range of 13 high fidelity, regular, economy and premium Taq
polymerase enzymes were selected: BiotaqH (Bioline, London, UK), FastStartH High
Fidelity PCR System (Roche, Mannheim, Germany), AmpliTaq GoldH (Applied
Biosystems, Warrington, UK), HotStarTaqH DNA Polymerase (Qiagen, Hilden,
Gernamy), PhusionH High Fidelity DNA Polymerase (Finnzymes, Espoo, Finland),
Taq DNA Polymerase (Roche, Maylan, France), i-MaxTM II DNA Polymerase
(iNtRON Biotechnology, Seongnam, Korea), KAPA HiFiTM (Kapa Biosystems,
Boston, USA), OneTaqTM DNA Polymerase (New England Biolabs, Hitchin, UK),
Figure 1 | Proportion of correct reads for the three genetic systems (simple: a single allele per individual, squares; medium: two alleles, circles; and
complex: multiple alleles, triangles) using standard PCR conditions (open) andmodified PCR conditions to reduce chimera formation (gray). The size
of the shape is indicative of the number of reads (see legend). All enzymes yielded at least 50% correct reads in the simplest system, mitochondrial DNA
(Test 1; open squares). Some enzymes only worked for a given set of conditions (cycling conditions/genetic system). A group of enzymes consisting of
Phusion, Gold and FastStart yielded a high proportion of correct reads cosistently accross all conditions. Others, such as Roche Taq, HotStar and Biotaq,
yielded a low percent of correct reads for the more complex systems (MHC class I and MHC class II). Abbreviations as defined in Table 1.
www.nature.com/scientificreports
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VentH DNA Polymerase (New England Biolabs, Hitchin, UK), Deep VentH DNA
Polymerase (New England Biolabs, Hitchin, UK), PwoH DNA Polymerase (Roche,
Maylan, France) and Velocity DNA Polymerase (Bioline, London, UK) (abbreviated
names in Table 1). The list price of these enzymes for the amount recommended for a
single 10 ml reaction (not including tax, handling or shipping) ranged from J0.01 to
J0.63 (Spain, June 2013).
Assessment of accuracy for different enzymes. Loci for Tests 1–3were amplified in a
two-step process following the universal tailed amplicon design proposed by
Roche24,25. First, loci were amplified with locus-specific primers with anM13 tail, and
then aMultiplex Identifier (MID) and the sequencing primer were added in a second-
round PCR using the same enzyme as for the first PCR. For Test 1, the 59 end of the
wolf mitochondrial control region was amplified with the primers Thr-L22 and ddl526,
which target a 168–172 bp fragment excluding primers (variation due to indels). For
Test 2, a 257 bp fragment of MHC II in horse was amplified with primers Be3 and
Be427. For Test 3, a 184 bp fragment of MHC I was amplified using primers
PpLAa2U270 and Ppa2L54228. In the second PCR, we used the first PCR as a template
with a 52 bp primer which included the M13, a sample-specific 10 bp MID, the 454
Sequencing System Primer sequence and a 4 bp primer key (Table 2).
All reactions were prepared in 10 ml using the standard PCR conditions following
the manufacturer’s protocols that came with each enzyme for both PCR steps. These
were 40 cycles of: 15 or 30 seconds at 94–98oC, 20, 30 or 90 seconds at 58oC, and 30, 60
or 90 seconds at 72oC; with a final extension at 72oC for 5, 7 or 10minutes. All cycling
was performed on a DNA Engine Peltier Thermal Cycler. All reactions, including
blank controls, were checked for amplification success on a 1.5% agarose gel and
visualized with SYBRHSafe (Invitrogen, Paisley, UK). All successful first PCR pro-
ducts were diluted and used as templates for the second-round PCRs. Second PCR
products were cleaned using Agencourt AMPure xp system (Beckman Coulter, Brea,
CA, USA).
Assessment of PCR protocols to reduce amplification errors.We repeated Tests 2
and 3 with modified cycling conditions in an attempt to reduce errors: Test 2b & 3b,
respectively. The goal was to generate comparable data to evaluate the effect of the
cycling conditions on the accuracy of the sequences (Test 2 vs 2b; Test 3 vs 3b). For the
first and second PCRs the number of cycles was reduced to 25, the elongation time
within cycles increased to 180 seconds and the final extension step was eliminated.
Similar amplifications conditions have been suggested previously in the literature to
reduce errors during amplification steps13,14,29–32. All the cycling reactions were
performed on a DNA Engine Peltier Thermal Cycler. All reactions, including blank
controls, were checked for amplification success on a 1.5% agarose gel and visualized
with SYBRHSafe (Invitrogen). All successful first PCR products were diluted and used
as templates for the second-round PCRs. Second PCR products were cleaned using
Agencourt AMPure xp system (Beckman Coulter, Brea, CA, USA).
Library preparation and sequencing. Purified PCR products from all tests were
quantified using Quant-it PicoGreen dsDNAAssay Kit (Invitrogen) in a Light Cycler
480 II real-time PCR machine (Roche). Then they were adjusted to equimolar
concentration (2x105 molecules/ml in TE buffer) and all amplification products were
pooled together. The pool was then quantified using the Quant-it PicoGreen dsDNA
Assay Kit (Invitrogen) on a QuantiFluorTM-ST fluorometer (Promega, US).
Emulsion PCR was performed according to the manufacturer’s instructions with
GS Junior Titanium emPCR Kit Lib-A (Roche) and sequenced in a single 454 Roche
Junior run.
Data Analysis. Reads containing the complete target primers and barcodes were
extracted from the multifasta output file and de-multiplexed on the basis of the
barcode and loci specific primer sequences using jMHC33. The different sequences
were compared to the known haplotype or genotype to determine correct sequences
in Geneious v6.1.7 (Biomatters, Auckland, NZ). These previously known sequences
were the reference against which the sequences identified in jMHC were compared,
and reads were considered to have the correct sequence when it was identical to the
reference. The proportion of correct reads was calculated by dividing the number of
reads with correct sequences by the total number of reads from a particular amplicon.
Statistical analysis.We evaluated the effect of enzymes on the proportion of correct
reads with generalized linear mixed models (GLMM), using the function lmer from
the lme4 package34 in R (Bates, D., Maechler, M. & Bolker, B. lme4: Linear mixed-
effectsmodels using S4 classes. R package version 0.999999-0. (2012); RCore TeamR:
A language and environment for statistical computing. R Foundation for Statistical
Computing, Vienna, Austria. http://www.R-project.org/ (2013)) for each test
separately. Only cases withmore than 10 reads per individual test were included in the
analysis. The Taq polymerase was included as a fixed effect and individual as a
random effect. We also used a GLMMwith lmer function to evaluate the effect of the
PCR protocol (standard/modified) on the proportion of correct reads for themedium
and complex systems (Test 2 vs Test 2b; Test 3 vs Test 3b). PCR condition was
Figure 2 | Probability of obtaining 3 or more correct sequences for a
given number of reads based on the proportion of correct reads observed
for each enzyme and genetic system. (A). For the simplest genetic system,
with only one allele per individual. (B). For a locus with two alleles that
amplify equally well (3 or more correct sequences for each of the two
alleles). (C). For a locus with two alleles where one amplifies twice as well as
the other. Note that the scale on the X-axis in panel A is different from that
in B and C.
Table 2 | Primers used in first and second round reactions for all tests.We used published primers (references in text) uponwhich anM13 tail
was added (shown in lower case). MIDs 1–9625 were used in both the forward and reverse primers
Test Primer Sequence 59 – 39
Test 1 Thr-L-t gttttcccagtcacgacGAATTCCCCGGTCTTGTAAACC
Test 1 ddl5-t aacagctatgaccatgCATTAATGCACGACGTACATAGG
Test 2 PpLAa2U270 -t gttttcccagtcacgacGCTTCTCATCCTAGTTCCCTT
Test 2 Ppa2L542-t aacagctatgaccatgGCCTAGGAGTGCAGCAGA
Test 3 Be3-t gttttcccagtcacgacGGGTCTCACACCYKCCAG
Test 3 Be4-t aacagctatgaccatgGMGCWGCAGSGTCTCYTT
Second round forward CGTATCGCCTCCCTCGCGCCATCAG[MID]gttttcccagtcacgac
Second round reverse CTATGCGCCTTGCCAGCCCGCTCAG[MID]aacagctatgaccatg
www.nature.com/scientificreports
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included as a fixed effect, and enzyme and individual as random effects. We tested the
significance of the variables by comparing different models using ANOVAs.
We prepared a script in Python 2.7.4 to calculate the probability of obtaining a
minimum of three reads with the correct sequences for the different Taq enzymes
when varying the total number of reads for a single haplotype and for one locus with
two alleles (the script is available in Supplementary file 2, online). These probabilities
are based on the frequency of correct reads observed per enzyme in Test 1 for the case
of the single haplotype, and Tests 2 & 2b combined for the case of one locus with two
alleles. Simulations were run only on datasets with .10 reads. We considered the
number of reads when this probability reached 99.9% as an indication of the coverage
needed with a given enzyme to be able to reliably identify the correct haplotype or
alleles in a genotype. Often, the different alleles inmulti-allelic systems do not amplify
equally within a reaction. For this reason we also calculated the probability of
obtaining three reads with the correct sequence for each allele when one amplifies half
as well as the other.
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